You are in : Home » Results & submissions » Select UOA » 34 - Art and Design: History, Practice and Theory » View submission: University of Northumbria at Newcastle » Outputs » Detail

Output details

34 - Art and Design: History, Practice and Theory

University of Northumbria at Newcastle

Return to search Previous output Next output

Output 22 of 137 in the submission

Title or brief description

Cartridge, medical apparatus and method

Type

F - Patent/published patent application

Patent registration number

WO2012123709 (A1)

Year

2012

URL

http://nrl.northumbria.ac.uk/10036/

Number of additional authors

Additional information

This invention resulted from mapping technology, market and medical research alongside intellectual property landscaping through a Multiple Perspective Problem Framing approach (English 2007, 2009, 2011). It is the world’s first non-invasive commercially viable in-home treatment for diabetic retinopathy and age-related macular degeneration.

The global prevalence of diabetes is expected to rise to 438 million by 2030, all are at risk of developing diabetic retinopathy that is treatable by this device.

The research began March 2010 as a £308k tri-party project involving Polyphotonix Ltd, Iconet Ltd and Northumbria University, a further £7.5m has been raised and the device is currently undergoing clinical trials.

Interdisciplinary

Cross-referral requested

Research group

None

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract